In-depth biotech analysis articles

In Depth 27 Apr 2017

Spain: An Emerging Star in the European Biotech Community

Take note, Spain is becoming a new hotspot for biotech in Europe. More than €400M of venture capital, counting recent fundraising and anticipated closings, is forecasted to be available this year to fund the creation and growth of start-ups in the life sciences sector. Behind the growing interest among investors are novel opportunities with breakthrough potential […]

April 27, 2017 - 6 minutesmins - By External Contributor

In Depth 11 Apr 2017

Social Impact and Biotech: A Founder Revisits the Business Models

A recent article published on Labiotech.eu provided some high-level insight into whether or not non-profit structures are suitable for biotechnology companies. In this article we dig a little deeper, and challenge some of the assumptions and hypotheses presented. Across the globe, there is a new movement of entrepreneurs emerging, which value making a positive impact with their […]

April 11, 2017 - 5 minutesmins - By External Contributor

In Depth 21 Mar 2017

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

As biopharma continues to weather a maelstrom of public scrutiny for its prices and profits, I asked executives about alternative models. Conventional wisdom in biotech is that the non-profit model can’t work in the industry: it takes a decade and billions in cash to develop a drug, with no guaranteed success. No investor would sink […]

March 21, 2017 - 7 minutesmins - By Evelyn Warner

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

Brain diseases are hard to treat, but biotechs are harnessing a variety of techniques, including immunotherapy and gene therapy, to target neurodegenerative disorders. When Eli Lilly announced that solanezumab, a long anticipated Alzheimer’s antibody, failed in their third attempt at a late stage trial last year, it crushed patients’ hopes and raised doubts about whether […]

January 31, 2017 - 7 minutesmins - By Diana Kwon

In Depth 5 Jan 2017

What to Expect from European Biotech Finance in 2017

The new year comes with uncertainty over the future of the biotech industry, whose finance suffered during 2016. What are the expert predictions for 2017? Last year was the worst for biotech finance in a decade. Despite the struggle, some companies managed to make outstanding deals, fundraising and exits in 2016 and experts seem convinced that the […]

January 5, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 29 Nov 2016

The ABCs of ADCs: A Review of Antibody Drug Conjugates

Antibody therapies have a little sister who is catching up in funding – and hype? In light of now five deaths from Juno’s CAR-T therapy, antibody drug conjugates are attracting a lot of interest in a resurgence after their debut 10 years ago. To feel out the field, we talked to two CEOs competing directly […]

November 29, 2016 - 8 minutesmins - By Evelyn Warner

biorefinery review europe biomass bioeconomy

In Depth 2 Nov 2016

Green Waste is Biotech’s New Black Gold: A Review of Biorefineries

Replacing petroleum-based products with biobased equivalents is the Holy Grail of the bioeconomy. What are biorefineries doing and how can Biotech help? ‘Biorefinery’ is a buzzword for a cool technological space that draws from GreenTech, Industrial Biotech and SynBio. The core concept behind it is relatively simple: these plants mimic the traditional petroleum refinery, but […]

November 2, 2016 - 5 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

In Depth

Spain: An Emerging Star in the European Biotech Community

Social Impact and Biotech: A Founder Revisits the Business Models

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

Biologicals on the Brain: Biotech in Neurodegenerative Disease

What to Expect from European Biotech Finance in 2017

The ABCs of ADCs: A Review of Antibody Drug Conjugates

Green Waste is Biotech’s New Black Gold: A Review of Biorefineries

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!